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Abstract
Research Article
IntroductIon
Classification of specific types of melanocytic lesions may be 
challenging for pathologists. Most importantly, differentiation 
between a benign and malignant lesion requires detection 
of subtle details such as cytomorphologic atypia and 
mitotic figures. A constant high quality of hematoxylin and 
eosin (H and E)‑stained slides, enabling assessment of all 
the required information at high magnification, is of utmost 
importance. The depth of field is lower for high magnification 
levels. Therefore, adjustment with the fine focusing knob of 
the microscope brings minute details in focus.
Today, the technique of whole slide imaging (WSI) has reached 
the point that glass slides can be scanned within minutes and 
the image quality qualifies for routine pathology diagnostics. 
In Europe, some WSI instruments have regulatory approval 
for diagnostic use marked by CE IVD (European Conformity 
for in vitro Diagnostic Medical Devices).[1] The technology 
has recently been approved by the United States Food and 
Drug administration (FDA) as an alternative to microscopic 
inspection of glass slides for primary diagnostics.[2] Several 
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pathology labs already render clinical diagnosis for routine 
patient care using WSI.[3] According to laboratory quality 
guidelines a validation process should be carried out before 
implementing WSI for clinical purposes.[4] For this purpose, the 
college of American pathologists (CAP) provided a guideline 
for validation of WSI.[5]
A number of dermatopathology WSI validation studies have 
been published.[6‑10] These studies show considerable variation 
in sample sizes, case selection, and types of lesions studied. Only 
two studies focused on the diagnosis of melanocytic lesions,[7,9] 
where image quality is of paramount importance. In these 
studies, concordance varied significantly (75.6% vs. 93.2%), 
which may be due to differences in the study design. One of 
the limitations of WSI, as it is most often used, is the lack of 
a multiplanar focusing option. Although many WSI devices 
are capable of providing software focusing (using so‑called 
z‑stacks: a series of images captured at the same spatial location 
with varying focus plane), this is hardly ever used in practice. 
The main reasons for this are the strongly increased scanning 
time and required storage space. To the best of our knowledge, 
no previous studies have investigated the potential increase in 
diagnostic accuracy of using software focusing for WSI‑based 
diagnostics in dermatopathology.
In the present study, we addressed this issue in the diagnosis 
of challenging melanocytic lesions. The first objective of 
this study is to establish the diagnostic accuracy of WSI 
for melanocytic lesions including difficult spitzoid lesions 
and nevoid melanoma. Our second objective is to study the 
potential accuracy increase of using z‑stack scanning including 
recognition of dermal mitoses.
MaterIals and Methods
Case selection and slide scanning
Benign nevi and malignant melanoma cases from 2011 to 2012 
were randomly selected from the archives of the Pathology 
Department of the Radboud UMC. The set was expanded 
with additional challenging cases comprising halo nevi, 
dysplastic nevi, and spitzoid nevi, on the basis of the original 
pathology reports. In addition, a set of ten nevoid melanomas 
was included, which were initially offered for consultation to 
the Pathology Department of the Radboud UMC. These cases 
were diagnosed as nevoid melanoma by a dermatopathologist 
with a special interest in the diagnosis of melanoma (WB). 
Diagnoses for all ten cases were subsequently confirmed 
by an independent consultant dermatopathologist (MC). In 
addition, five of these cases were also confirmed by the EORTC 
melanoma group (fall meeting, Barcelona, 2011).
From every case (n = 102 in total), one representative 
H and E slide was selected. All cases were scanned using 
a Pannoramic 250 Flash II scanner (3DHistech, Hungary; 
using a ×20 objective lens, specimen‑level pixel size, 
0.243 µm × 0.243 µm, and applying 80% of JPEG compression 
rate). This optical setup results in an on‑screen magnification 
comparable to a ×400 magnification when using a conventional 
microscope. The slides were scanned in z‑stack mode, using 
seven levels with an interplane distance of 0.6 µm. Resulting 
images were examined on a computer screen at a resolution 
that is comparable to the use of a ×400 magnification at a 
traditional light microscope.
Reference standard
Three academic pathologists (referred to as “reference 
pathologists”) specialized in dermatopathology (WB, WM, and 
DC) revised the original glass slides of 92 cases, except for the 
nevoid melanomas (n = 10). Cases were offered with clinical 
information (age, gender, and location on the skin) and were 
classified as either benign, malignant, or melanocytic tumor of 
unknown malignant potential (MELTUMP) with subsequent 
specific diagnosis in concordance with the WHO classification 
of melanocytic lesions.[11] For lesions classified as malignant 
or MELTUMP, the presence of dermal mitotic activity had to 
be assessed. In addition, lesions classified as MELTUMP were 
stratified into low risk and high risk.[12]
The reference standard was achieved by applying a four‑tier 
system: benign (n = 1), MELTUMP low risk (n = 2), 
MELTUMP high risk (n = 3), and malignant (n = 4). If at least 
two reference pathologists agreed on a diagnosis and the third 
pathologist disagreed with a difference of at maximum one 
category, the majority diagnosis was taken as the reference 
standard. Cases, where one reference pathologist classified 
a lesion two categories or more differently, were admitted 
blindly to all three reference pathologists again, in an attempt 
to achieve consensus in a second round. If still no consensus 
was reached, the case was labeled as “discordant” and excluded 
from the study.
Dermal mitotic activity was defined as “present” if at least two 
reference pathologists had registered this. Cases, where only 
one of the three pathologists registered a dermal mitosis, were 
re‑assessed specifically for dermal mitotic activity by one of 
the three reference pathologists (WB).
Whole‑slide imaging assessment
The set of whole‑slide images (n = 102) was assessed by 
six nonacademic surgical pathologists (referred to as “study 
pathologists”), with a subspecialty in dermatopathology 
(AO, CW, EE, EK, HK, and MvD). Cases were diagnosed using 
Pannoramic Viewer (3DHistech, version 1.15.4) on a 24‑inch 
ultra HD color calibrated monitor (Dell UltraSharp; resolution: 
3840 × 2160 pixels). Calibration of the monitor was performed 
using a Datacolor Spyder3 Elite colorimeter. The participating 
pathologists followed a short course using the slide viewer, 
particularly emphasizing the software focusing option. They 
were instructed to assess a WSI first without using the software 
focusing option. Subsequently, the study pathologists were 
allowed to immediately re‑assess the WSI using the software 
focusing option, if deemed necessary. All cases, including 
nevoid melanoma, were offered to the study pathologists with 
clinical information (age, gender, and location on the skin) and 
were classified identical to the classification performed by the 
reference pathologists (i.e., using a four‑tier system).
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Statistical analysis
For statistical analysis, the four‑tier scheme defined above 
was downsized to a three‑tier system by combining high‑risk 
and low‑risk MELTUMP, as clinical management of these 
lesions is largely identical. Concordance of pathologists with 
the consensus diagnosis was expressed as the number and 
percentage of cases with identical diagnosis (in the three‑tier 
system) for every subclass as well as overall. As an overall 
measure of concordance of the study pathologists with the 
consensus diagnosis, Kappa statistics with 95% confidence 
intervals (CIs) were calculated. The effect of using software 
focusing was analyzed using Chi‑Square tests with 95% CIs.
results
A consensus diagnosis by the reference pathologists could 
initially be achieved in 81 (88%) of 92 cases. After blindly 
admitting discordant cases (n = 11) a second time to the 
individual reference pathologists, consensus was reached in 
89 (97%) of the cases. Therefore, the set of WSI assessed 
by the study pathologists contained 99 cases (35 benign, 
4 MELTUMP, and 60 malignant, including 10 nevoid 
melanoma). The concordance of the individual reference 
pathologists with the consensus diagnosis is shown in Table 1. 
Except for MELTUMP cases, concordance exceeded 91% 
for every pathologist for both benign and malignant cases. 
MELTUMP concordances were lower (average 66.7%), but 
the set of cases was very small (n = 4). It should be noted that 
in Table 1, reference pathologists’ diagnoses are compared 
with the reference diagnosis, which itself was partly based 
on the studied diagnoses. The purpose of this analysis is to 
better understand the quality of the reference standard used 
here and should not be considered an independent measure for 
individual pathologists’ performance.
WSI assessment by the six study pathologists was primarily 
studied without the use of the software focusing option, 
as this is the generally accepted method in which WSI is 
used. WSI assessment by the six study pathologists against 
the consensus diagnosis is shown in Table 2. Results of 
the ten nevoid melanoma cases are displayed separately. 
Concordance generally exceeds 80% for individual 
pathologists. Interestingly, the majority of study pathologists 
classified most MELTUMP cases as either benign or 
malignant. Furthermore, two pathologists (Path 3 and Path 4) 
misdiagnosed the large majority of nevoid melanoma, which 
are notoriously difficult, as being benign in almost all cases. In 
one case, a nevoid melanoma was classified as a MELTUMP 
high risk (Path 3). Kappa statistics for these assessments 
are shown in Table 3, for the set of cases not including the 
nevoid melanoma (n = 89). As nevoid melanomas occur rarely 
in pathology diagnostic practice, we consider this the most 
representative way of analysis. The facultative use of software 
focusing did not show a significant change (Chi‑square test 
P = 0.85) in concordance with the consensus diagnosis as 
shown in Table 4. Although not significant, study pathologist 5 
changed the diagnosis once from benign (incorrect diagnosis) 
to a melanoma (correct diagnosis) after use of the software 
focusing.
In the malignant and MELTUMP cases (n = 54), dermal 
mitosis was initially detected in 35 cases by at least one of 
the three reference pathologists. In ten of these 35 cases, only 
one of the three reference pathologists mentioned dermal 
mitosis. After reviewing these ten cases (WB), only three 
cases with dermal mitotic activity remained, establishing 
28 out of 54 melanomas and MELTUMP cases with dermal 
mitotic activity.
Recognition of dermal mitotic activity did not improve 
significantly using the software focusing option concerning the 
Table 1: Concordance of individual reference pathologists 
with consensus diagnosis based on glass slides
Benign MELTUMP Malignant Overall
Number of cases 35 4 50 89
Reference pathologists
1 33 (94) 3 (75) 50 (100) 86 (97)
2 32 (91) 3 (75) 48 (96) 83 (93)
3 33 (94) 2 (50) 48 (96) 83 (93)
Average (%) 93 67 97 94
Number of cases concordant with consensus diagnosis. Percentage within 
brackets. “Average” shows the average concordance (%) over the three 
pathologists. MELTUMP: melanocytic tumor of unknown malignant 
potential
Table 2: Concordance of individual study pathologists with consensus diagnosis without use of z‑stack
Benign MELTUMP Malignant Nevoid melanomas Overalla Overallb
Number of cases 35 4 50 10 89 99
Path 1 29 (83) 2 (50) 45 (90) 8 (80) 76 (85) 84 (85)
Path 2 34 (97) 0 (0) 45 (90) 7 (70) 79 (89) 86 (87)
Path 3 33 (94) 1 (25) 38 (76) 2 (20) 72 (81) 74 (75)
Path 4 33 (94) 0 (0) 34 (68) 1 (10) 67 (75) 68 (69)
Path 5 32 (91) 0 (0) 43 (86) 8 (80) 75 (84) 83 (84)
Path 6 34 (97) 0 (0) 46 (92) 8 (80) 80 (90) 88 (89)
Average (%) 93 13 84 57 84 81
Number of cases concordant with consensus diagnosis. Percentage within brackets. “Average” shows the average concordance (%) over the six 
pathologists. aOverall number of cases excluding nevoid melanoma cases; bOverall number of cases including nevoid melanoma cases. MELTUMP: 
melanocytic tumor of unknown malignant potential
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above, this subsequently changed the diagnosis once from 
benign (incorrect) into (nevoid) melanoma. In the remaining 
four cases, the diagnosis remained melanoma.
dIscussIon
Multiple studies have been carried out to assess the interobserver 
variability concerning diagnosis of melanocytic lesions on 
glass slides. These studies vary in design, for example, number 
of cases, selection of cases, and experience of pathologists. In 
this study, we did not include the use of ancillary techniques 
like immunohistochemistry, because we believe it will not 
influence the diagnosis on digital slides compared to glass 
slides. Nevertheless, various studies that (partly) approximate 
the study we performed are available. For example, Elmore 
et al. studied concordance of 240 melanocytic lesions among 
187 pathologists with 48 cases per pathologist.[13] In that 
particular study, the cases were classified according to the 
Melanocytic Pathology Assessment Tool and Hierarchy for 
Diagnosis (MPATH‑Dx) into five classes, i.e., I (e.g., nevus or 
mild atypia); II (e.g., moderate atypia); III (e.g., severe atypia or 
nonnevoid melanoma cases. Pathologist 1 changed three times 
the status of dermal mitotic activity: twice into true positive and 
once into false negative [Figure 1]. Pathologist 5 changed three 
times, all into false positive. The remaining pathologists did 
not change the status of dermal mitotic activity. Noteworthy, 
concerning the nevoid melanoma cases is the fact that study 
pathologist 5 changed the status of dermal mitotic activity in 
five of the ten cases from negative into positive. As mentioned 
Table 3: Kappa values (95% confidence interval) of 
individual study pathologists for all cases excluding 
nevoid melanoma
κ (n=89)
Path 1 0.74 (0.60‑0.85)
Path 2 0.79 (0.67‑0.91)
Path 3 0.66 (0.51‑0.79)
Path 4 0.55 (0.39‑0.70)
Path 5 0.72 (0.58‑0.83)
Path 6 0.81 (0.69‑0.91)
Table 4: Concordance of individual study pathologists with consensus diagnosis (n=99) with and without use of software 
focusing, i.e., z‑stack
z‑stack use (n) Concordance without z‑stack (%) Change of diagnosis (n) Concordance with z‑stack (%)
Path 1 28 82 3 82
Path 2 7 100 0 100
Path 3 26 73 0 73
Path 4 3 67 0 67
Path 5 22 82 1 86
Path 6 12 92 0 92
Number of cases z‑stack is used, number of change of diagnosis and concordance (%) with consensus before and after z‑stack is used
Figure 1: Examples of changes in the status of dermal mitotic activity by pathologist 1 after the use of software focusing. Case 7 (a) changed into 
true positive. Case 59 (b) changed into false negative. Case 97 (c) changed into true positive. Note that the best field of view of the mitosis is situated 
mainly below and above the zero z‑plane in cases 7 and 97, respectively
c
b
a
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melanoma in situ); IV (e.g., pathologic stage T1a [pT1a] early 
invasive melanoma); and V (e.g., ≥pT1b invasive melanoma), 
and 53 and 134 participants were academic and nonacademic 
pathologists, respectively. Overall interobserver concordance 
with the diagnosis of benign nevi was  92% (90–94), early 
invasive melanoma 43% (39–46), and (clearly) invasive 
melanoma 72% (69–75). Lott et al. carried out a comparable 
study of 48 cases classified according to the MPATH‑Dx 
among 16 pathologists considered to be experts in the 
typing of melanocytic lesions, including 14 academic and 
2 nonacademic.[14] This study showed that concordance of 
benign lesions was 87.8%, (…), early invasive and (clearly) 
invasive melanoma grouped together 87.0% presuming the 
most severe diagnosis. Interobserver agreement with weighted 
kappa coefficients was 0.72 (95% CI: 0.71–0.73) assuming the 
most severe diagnosis. A final example concerning glass slides 
is the study carried out by Corona et al. This interobserver 
study concerned 140 melanocytic lesions, of which 120 were 
melanoma among four dermatopathologists with at least 
10 years of experience.[15] Overall concordance concerning 
melanoma was 81%, and kappa interobserver agreement was 
0.61 (95% CI: 0.54–0.68). Obviously, the figures obtained in 
these studies are heavily dependent on the selection of cases 
studied.
In the past two decades, a number of WSI validation studies have 
been performed.[3,16] WSI studies specifically for melanocytic 
lesions are small in number, especially those applying the CAP 
guidelines.[5] Shah et al. studied 181 cases for concordance of 
skin lesions, of which 60 concerned melanocytic lesions.[9] It 
was found that pathologists achieved an overall interobserver 
concordance of 82.8% concerning light microscopy versus light 
microscopy and 80.0% concerning WSI versus WSI in these 
60 cases. It was found that pathologists achieved an overall 
intraobserver concordance of 75.6% (95% CI: 68.5–81.5) 
concerning WSI versus light microscopy.
In a larger study, Leinweber et al. reported on 560 melanocytic 
lesions, of which 280 were clearly malignant and 280 clearly 
benign, which were examined by four academic pathologists.[7] 
In this study, interobserver agreement was not evaluated. 
Overall intraobserver concordance was 93.2% (90.4–96.4).
The results of our study, if we exclude all nevoid melanoma 
cases, are in line with the studies mentioned above. Agreement 
between the reference pathologists with the consensus 
diagnosis appears to be higher in our study. Reasons for this 
can be multiple, for example, methodology, quality of the 
H and E slides, a second read of discordant cases, methodology 
of reaching consensus, and less difficult cases. Agreement 
between the study pathologists is in accordance with other WSI 
validation studies, although the number of studies available 
is relatively small. Overall concordance is 84% (75%–90%; 
n = 89) compared to 80.0% (n = 60) in the study of Shah et al.[9]
Recognition of nevoid melanoma is a challenge and is a known 
pitfall among pathologists.[17] The results in this study show 
a bimodal distribution. Four pathologists recognized seven to 
eight of the ten cases on WSI; two pathologists recognized, 
respectively, two and one of the cases only. Although the 
literature yields no exact data, in our opinion, these results 
reflect the existing daily practice. That stated, it may be 
possible the bimodal distribution can be attributed to the fact 
some study pathologists have no prior experience examining 
WSI. Pathologists 1 and 2 have significant WSI experience; 
the remaining pathologists have not. Therefore, it appears that 
WSI experience is not of significant importance to recognize 
nevoid melanoma as such.
So far, only two studies focused on the possible advantage 
of software focusing, i.e., z‑stack scanning, in histology.[18,19] 
Specifically, in dermatopathology, concerns have emerged that 
WSI may not sufficiently allow identification of mitosis, which 
is an important feature for the diagnostic evaluation of many 
melanocytic lesions.[20] In the field of surgical neuropathology, 
Pekmezci et al. stated that the major reason for undergrading 
in brain tumor cases was the inability to recognize mitosis in 
WSI review.[21]
Studies concerning software focusing are mainly done in the 
field of cytology.[22,23] We note that in the field of histology, 
only one study has been reported.[18] Kalinski et al. showed that 
software focusing could be of value to improve the detection of 
the microorganism Helicobacter pylori in gastric biopsies. The 
assessment of inflammation and intestinal metaplasia did not 
improve. Snead et al. stated that the omission of multiplanar 
scanning in histology samples does not seem to be a common 
problem, where sections in recent days are cut at 4 µm by most 
pathology departments.[19] To our knowledge, this statement is 
not substantially scientifically proven. Due to this lacuna in the 
literature, the study we performed may be the first to proof to 
underline this statement concerning melanocytic lesions. We 
believe that our study shows that, in general, the use of software 
focusing appears not to be of great significance to render a 
more accurate diagnosis in melanocytic lesions, including 
nevoid melanoma. Furthermore, in general, it does not provide 
a better recognition of mitosis. False negative cases were 
mainly missed dermal mitoses that were unmistakably present. 
The cases in which pathologist 1 and 5 changed the status 
of dermal mitotic activity after the use of software focusing 
were reviewed (n = 6, all non‑nevoid melanomas) (BS). In 
the cases of pathologist 5, i.e. all false positive mitoses, it was 
not possible to find the dermal mitoses on WSI and the glass 
slides. Although in one case an epidermal mitosis could have 
been mistaken for a superficial dermal mitosis. Interestingly, 
in the ten nevoid melanoma cases, one of the six pathologists 
changed the status of dermal mitotic activity in five cases from 
negative into positive and subsequently changed the diagnosis 
once from benign into nevoid melanoma. Although the dermal 
mitotic activity was not confirmed by the study pathologists 
due to the study design, this fact may be relevant resulting in 
the following hypothesis: “concerning melanocytic lesions, 
in very challenging cases, a software focusing option may 
be of added value to recognize (dermal) mitosis with more 
confidence, resulting in a more accurate diagnosis.” Therefore, 
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in a melanoma consulting pathology practice, z‑stack scanning 
may be of utmost importance to achieve and maintain the 
highest degree of diagnostic accuracy. Although this statement 
has to be proven or falsificated by future research.
A downside of WSI z‑stack scanning is that the scanning time 
and storage needed for each slide are linear with the number of 
z‑planes scanned. In our study, the file size of each WSI was 
seven times the size of a normal WSI.
conclusIon
Diagnostic accuracy of melanocytic lesions based on glass 
slides and WSI is comparable with previous publications, 
however, small in number they are. A large variability in 
diagnostic accuracy of nevoid melanoma does exist, which 
reflects daily practice, but may partly be caused by the use of 
WSI. Importantly, our results show that z‑stack scanning, in 
general, does not increase diagnostic accuracy of melanocytic 
lesions concerning classification and detection of dermal 
mitosis. Establishing this knowledge is important because it 
may prevent unnecessary investments in, for example, data 
storage.
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